19 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

REDUCED SIZE ONCOLOGY SALVAGE SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

IMMULITE 2000 3GALLERGY SPECIFIC IGE

FDA Adverse Event
Malfunction ·SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED·Product code DHB·May 22, 2018

ALLROUND 55 LF

FDA 510(k)
FDA Class 2 ·Dental

WIENER LAB. UREA UV CINETICA AA

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

HYBRID GLENOID IMPACTOR

FDA Adverse Event
Malfunction ·ZIMMER BIOMET, INC.·Product code HWA·September 10, 2019

IMMULITE 2000 3GALLERGY SPECIFIC IGE

FDA Adverse Event
Malfunction ·SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED·Product code DHB·May 22, 2018

COMPR RVS GLENO 2-PRNG INS/IMP

FDA Adverse Event
Malfunction ·ZIMMER BIOMET, INC.·Product code KWS·September 10, 2019

SIDEKICK

FDA Adverse Event
Malfunction ·NIPRO DIAGNOSTICS, INC.·Product code NBW·March 21, 2013

HOMECHOICE AUTOMATED PD SET WITH CASSETTE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FKX·March 16, 2011

TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC·Product code NIQ·March 28, 2008

SPEEDSTITCH MAGNUMWIRE SUTURE CARTRIDGES

FDA Adverse Event
Malfunction ·ARTHROCARE CORPORATION·Product code GAT·March 21, 2012

SPEEDSTITCH MAGNUMWIRE SUTURE CARTRIDGES

FDA Adverse Event
Malfunction ·ARTHROCARE CORPORATION·Product code GAT·March 21, 2012

SPEEDSTITCH SUTURING DEVICE

FDA Adverse Event
Malfunction ·ARTHROCARE CORPORATION·Product code GAT·March 21, 2012

SPEEDSTITCH MAGNUMWIRE SUTURE CARTRIDGES

FDA Adverse Event
Malfunction ·ARTHROCARE CORPORATION·Product code GEI·March 21, 2012

SPEEDSTITCH SUTURING DEVICE

FDA Adverse Event
Malfunction ·ARTHROCARE CORPORATION·Product code GAT·March 21, 2012

CR TIBIAL INSERT SZ 4, 9MM, SLOPE +

FDA Adverse Event
Injury ·EXACTECH, INC.·Product code JWH·June 15, 2023

CDI Blood Parameter Monitoring System 500 Cardiopulmonary bypass on-line blood gas monitor Product Usage: The CDL System 500 provides continuous, on-line monitoring of the extracorporeal partial pressure of oxygen and carbon dioxide, pH, potassium, oxygen saturation, hematocrit, hemoglobin and temperature. In addition, calculated values of base excess, bicarbonate, oxygen saturation, and oxygen consumption may also be provided. These parameters are displayed at either actual temperature or adjusted to 37 C. For documentation purposes, the system 500s integral printer provides a hard copy of displayed parameters.

FDA Enforcement
Class II ·Terminated·Terumo Cardiovascular Systems Corporation·April 6, 2016

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.

FDA Enforcement
Class II ·Terminated·Welch Allyn Protocol, Inc·January 15, 2014